A detailed history of Janney Montgomery Scott LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 737,124 shares of BMY stock, worth $43.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
737,124
Previous 714,616 3.15%
Holding current value
$43.4 Million
Previous $29.7 Million 28.51%
% of portfolio
0.11%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $892,667 - $1.16 Million
22,508 Added 3.15%
737,124 $38.1 Million
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $9.03 Million - $11.9 Million
-224,462 Reduced 23.9%
714,616 $29.7 Million
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $4.21 Million - $4.77 Million
87,690 Added 10.3%
939,078 $50.9 Million
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $4.69 Million - $5.6 Million
96,733 Added 12.82%
851,388 $43.7 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $518,810 - $580,110
-8,962 Reduced 1.17%
754,655 $43.8 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $470,307 - $522,202
7,382 Added 0.98%
763,617 $48.8 Million
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $1.09 Million - $1.23 Million
16,564 Added 2.24%
756,235 $52.4 Million
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $1.02 Million - $1.2 Million
-14,829 Reduced 1.97%
739,671 $53.2 Million
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $135 - $80,374
-1,046 Reduced 0.14%
754,500 $53.6 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $6.97 Million - $7.68 Million
-95,994 Reduced 11.27%
755,546 $59.3 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $1.13 Million - $1.36 Million
18,391 Added 2.21%
851,540 $62.2 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $521,283 - $607,694
-9,720 Reduced 1.15%
833,149 $51.9 Million
Q3 2021

Oct 29, 2021

SELL
$59.17 - $69.31 $4,141 - $4,851
-70 Reduced 0.01%
842,869 $49.9 Million
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $2 Million - $2.18 Million
-32,287 Reduced 3.69%
842,939 $56.3 Million
Q1 2021

Apr 27, 2021

BUY
$59.34 - $66.74 $820,968 - $923,347
13,835 Added 1.61%
875,226 $55.3 Million
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $1.79 Million - $2.03 Million
30,950 Added 3.73%
861,391 $53.4 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $1.55 Million - $1.71 Million
26,942 Added 3.35%
830,441 $50.1 Million
Q2 2020

Jul 23, 2020

BUY
$54.82 - $64.09 $2.05 Million - $2.39 Million
37,320 Added 4.87%
803,499 $47.2 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $132,054 - $191,905
2,846 Added 0.37%
766,179 $42.7 Million
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $2.57 Million - $3.35 Million
52,200 Added 7.34%
763,333 $49 Million
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $3.32 Million - $3.94 Million
77,690 Added 12.26%
711,133 $36.1 Million
Q2 2019

Jul 29, 2019

SELL
$44.62 - $49.34 $3.73 Million - $4.12 Million
-83,495 Reduced 11.65%
633,443 $28.7 Million
Q1 2019

Apr 30, 2019

BUY
$45.12 - $53.8 $6.24 Million - $7.44 Million
138,363 Added 23.91%
716,938 $34.2 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $102,152 - $132,466
-2,095 Reduced 0.36%
578,575 $30.1 Million
Q3 2018

Nov 05, 2018

SELL
$55.19 - $62.25 $554,549 - $625,488
-10,048 Reduced 1.7%
580,670 $36 Million
Q2 2018

Jul 24, 2018

SELL
$50.53 - $62.98 $269,628 - $336,061
-5,336 Reduced 0.9%
590,718 $32.7 Million
Q1 2018

Apr 19, 2018

SELL
$59.92 - $68.98 $424,533 - $488,723
-7,085 Reduced 1.17%
596,054 $37.7 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $925,353 - $1.01 Million
-15,438 Reduced 2.5%
603,139 $37 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $34.2 Million - $39.4 Million
618,577
618,577 $39.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.